Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial.
McMahon JH, Lau JSY, Coldham A, Roney J, Hagenauer M, Price S, Bryant M, Garlick J, Paterson A, Lee SJ, O'Bryan J, Hearps A, Tachedjian G, Pinskier H, Phillips C, Garrow S, Pinskier N, Melvin R, Blakeway L, Wisniewski JA, Byers S, Badoordeen GZ, Pereira S, Pragastis K, Trubiano JA, Chua KYL, Kainer M, Molton JS, Gardiner BJ, Pierce AB, Cheng A, Rogers BA, Peleg AY.
McMahon JH, et al. Among authors: kainer m.
EClinicalMedicine. 2022 Oct 20;54:101703. doi: 10.1016/j.eclinm.2022.101703. eCollection 2022 Dec.
EClinicalMedicine. 2022.
PMID: 36284645
Free PMC article.